MAXLINEAR, INC·4

May 5, 4:12 PM ET

Tewksbury Ted L III 4

4 · MAXLINEAR, INC · Filed May 5, 2026

Research Summary

AI-generated summary of this filing

Updated

MaxLinear (MXL) Director Ted Tewksbury Sells Shares After RSU Vest

What Happened

  • Ted L. Tewksbury III, a director of MaxLinear, had 15,741 restricted stock units (RSUs) vest on May 1, 2026 and acquired 15,741 shares at no cash cost (conversion of RSUs).
  • He sold a total of 10,660 shares in three open-market transactions (2,790 @ $78.67 on 5/1; 3,935 @ $77.36 on 5/4; 3,935 @ $80.00 on 5/5), generating aggregate proceeds of $838,687.
  • The sales were executed under a pre-established Rule 10b5-1 trading plan. These transactions are routine sales of newly vested shares rather than new purchases.

Key Details

  • Dates and prices:
    • 2026-05-01: Acquired 15,741 shares via RSU conversion (reported as M, $0.00).
    • 2026-05-01: Sold 2,790 shares @ $78.67 — $219,475 proceeds.
    • 2026-05-04: Sold 3,935 shares @ $77.36 — $304,412 proceeds.
    • 2026-05-05: Sold 3,935 shares @ $80.00 — $314,800 proceeds.
    • Total sold: 10,660 shares for $838,687.
  • Shares owned after transaction: The filing does not state total holdings, but based on this report he retained 5,081 shares from the vested award (15,741 acquired − 10,660 sold).
  • Footnotes:
    • F1: Sales were effected pursuant to a Rule 10b5-1 plan adopted June 2, 2025.
    • F2/F3: Each RSU equals one share; 100% of the RSUs vested on May 1, 2026.
  • Timeliness: Form 4 was filed on May 5, 2026 — within the required two business days of the May 1–5 transactions.

Context

  • These transactions reflect RSU vesting and subsequent planned sales, a common way insiders realize compensation value; they are not new open-market purchases (which are often viewed as stronger bullish signals).
  • For simplicity: "exercised/converted" here means RSUs converted into common shares (no cash cost), and some of those shares were sold under the prearranged 10b5-1 plan.

Insider Transaction Report

Form 4
Period: 2026-05-01
Transactions
  • Sale

    Common Stock

    2026-05-01$78.67/sh2,790$219,47572,205 total
  • Exercise/Conversion

    Common Stock

    2026-05-01+15,74187,946 total
  • Sale

    Common Stock

    [F1]
    2026-05-04$77.36/sh3,935$304,41284,011 total
  • Sale

    Common Stock

    [F1]
    2026-05-05$80.00/sh3,935$314,80080,076 total
  • Exercise/Conversion

    Restricted Stock Units

    [F2][F3]
    2026-05-0115,7410 total
    Common Stock (15,741 underlying)
Footnotes (3)
  • [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on June 2, 2025 by the Reporting Person.
  • [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock.
  • [F3]One hundred percent (100%) of the RSUs subject to the award vested on May 1, 2026.
Signature
/s/ Connie Kwong, as Attorney-in-Fact|2026-05-05

Documents

1 file
  • 4
    wk-form4_1778011943.xmlPrimary

    FORM 4